PRO Medicus Limited PMCUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 29.24% | 28.63% | 27.44% | 27.71% | 29.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.24% | 28.63% | 27.44% | 27.71% | 29.91% |
| Cost of Revenue | 36.95% | 24.87% | 11.71% | 5.68% | 1.42% |
| Gross Profit | 29.23% | 28.63% | 27.47% | 27.74% | 29.96% |
| SG&A Expenses | 19.17% | 24.19% | 29.11% | 23.86% | 19.98% |
| Depreciation & Amortization | 17.48% | 10.87% | 4.02% | -7.42% | -16.27% |
| Other Operating Expenses | 410.42% | -9.24% | -179.68% | -119.28% | -58.92% |
| Total Operating Expenses | 24.18% | 21.62% | 18.48% | 13.94% | 10.81% |
| Operating Income | 31.02% | 31.20% | 30.90% | 33.34% | 38.29% |
| Income Before Tax | 140.43% | 138.38% | 135.11% | 89.85% | 38.02% |
| Income Tax Expenses | 142.62% | 139.53% | 135.09% | 91.47% | 40.47% |
| Earnings from Continuing Operations | 139.51% | 137.90% | 135.12% | 89.18% | 37.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 139.51% | 137.90% | 135.12% | 89.18% | 37.03% |
| EBIT | 31.02% | 31.20% | 30.90% | 33.34% | 38.29% |
| EBITDA | 30.99% | 31.20% | 30.92% | 33.33% | 38.25% |
| EPS Basic | 139.53% | 137.92% | 135.10% | 89.17% | 37.00% |
| Normalized Basic EPS | 31.17% | 30.26% | 28.77% | 32.00% | 37.89% |
| EPS Diluted | 139.55% | 137.90% | 135.10% | 89.20% | 37.05% |
| Normalized Diluted EPS | 31.16% | 30.25% | 28.72% | 31.94% | 37.91% |
| Average Basic Shares Outstanding | 0.00% | 0.01% | 0.02% | 0.03% | 0.03% |
| Average Diluted Shares Outstanding | -0.01% | 0.02% | 0.04% | 0.03% | 0.01% |
| Dividend Per Share | 32.04% | 30.82% | 28.96% | 31.01% | 35.48% |
| Payout Ratio | -0.42% | -0.42% | -0.43% | -0.30% | -0.03% |